Stem Cell Reporter Gene System for Homogeneous Population Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating stem cells committed to differentiate into specific phenotypes result in heterogeneous populations due to the presence of antigens on different cell types, leading to incomplete enrichment and selection.
Innovation Solution
A stem cell modification method involving DNA molecules with specific sequences for protein interactions, indicator molecules, and minimal promoters, allowing for the identification and selection of stem cells committed to differentiate into a specific phenotype through artificial introduction, stimulus application, and subsequent identification and separation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If antibodies recognizing cell surface antigens (CD34 or CD133) are used for selection, then partial enrichment of stem cells is achieved, but heterogeneous stem cell populations result because these antigens are present on different cell types
Solution Approach 1:
The patent introduces a reporter gene system as an intermediary mechanism. Instead of directly selecting based on natural cell surface antigens that exist on multiple cell types, the invention uses artificially introduced DNA molecules with binding sites for specific transcription factors. When the transcription factor binds to its specific binding site, it activates the reporter gene (e.g., GFP), creating a visible marker that indirectly indicates commitment to a specific lineage. This intermediary reporter system allows precise selection of committed stem cells without the heterogeneity problem of natural antigen-based selection.
Solution Approach 2:
The patent replaces the biological/chemical mechanism of natural antigen-antibody interaction with a genetically engineered DNA-protein interaction system. Instead of relying on the mechanical/chemical binding of antibodies to cell surface antigens, the invention uses transcription factor-DNA binding that triggers gene expression. This substitution allows for more specific and controllable selection, as the reporter gene activation provides a clear, binary signal (on/off) that directly reflects transcription factor activity and thus lineage commitment.
2Productivity
If conventional stem cell isolation methods are used, then stem cells can be obtained, but the resulting population is heterogeneous with cells committed to different phenotypes
Solution Approach 1:
The patent implements a feedback mechanism through the reporter gene system. The expression of the reporter gene (such as green fluorescent protein) provides real-time visual feedback about the activity of lineage-specific transcription factors within the stem cell population. This feedback allows researchers to identify and isolate only those cells that have activated the appropriate transcription factors and are therefore committed to a specific phenotype, thereby achieving high manufacturing precision in stem cell differentiation commitment.
3Measurement precision
If antibodies with fluorescence markers are used for FACS selection, then CD34 or CD133 positive cells can be isolated, but incomplete enrichment occurs due to antigen presence on different cells
Solution Approach 1:
The patent applies preliminary action by genetically modifying the stem cells beforehand with the reporter gene system. Before performing any selection or enrichment, the cells are already equipped with the DNA molecule containing the binding site for the lineage-specific transcription factor and the reporter gene. This preliminary genetic modification ensures that when the cells are later exposed to the transcription factor or differentiation conditions, the reporter gene will be activated in the appropriate cells, making them easily identifiable and selectable. This preliminary preparation eliminates the need for incomplete antigen-based enrichment and allows for precise selection of committed stem cells.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the isolation of homogeneous populations of stem cells committed to differentiate into a specific type, facilitating targeted applications in vitro and in vivo, and improving tissue engineering and disease treatment approaches.
Implementation Method 1
at least one binding site sequence being apt to interact with the protein molecule
Data Source
AI summary
The stem cell (1) includes a cellular DNA (2) comprising a plurality of sequences coding different genes and promoters allowing DNA-protein-interactions, at least one protein molecule (3) generated by means of a specific stimulus (12) and at least one DNA-molecule (6) artificially introduced into the stem cell (1).The artificially introduced DNA-molecule (6) comprises at least one binding site sequence (30) being apt to interact with the protein molecule (3), at least one DNA-sequence (40) coding an indicator molecule (5) and at least one minimal promoter sequence (50), allowing the gene expression of said indicator molecule (5), whereby the stem cell further includes at least one indicator molecule (5) having properties allowing its identification and is produced by synthesis of the DNA-sequence (40) coding an indicator molecule (5) of the artificially introduced DNA-molecule (6).